Q0517 Pharmacy supplying fee for hiv pre-exposure prophylaxis fda approved prescription oral drug, per 60-days

Short descriptor: Supply fee hiv prep oral 60

⚠ Terminated HCPCS Level II 2026
Terminated Code
Q0517 was terminated as of 2024-12-31 and should not be reported for dates of service after that date. This page is retained for historical reference.
Open Q0517 in the app →

Look up Q0517 alongside ICD-10-CM diagnoses, the HCPCS Table of Drugs, and the AI coding assistant.

Q0517 is the HCPCS Level II code for Pharmacy supplying fee for hiv pre-exposure prophylaxis fda approved prescription oral drug, per 60-days (2026). It belongs to Section Q — Temporary Codes. Under Medicare, its coverage status is: Special coverage instructions apply. Part B pricing methodology: Carrier priced.

Classification & CMS Attributes

Medicare Coverage
Special coverage instructions apply (code D)
Part B Pricing
Carrier priced (indicator 46)
Type of Service
Other medical items or services
Effective Date
2025-01-01
Termination Date
2024-12-31
2026 Maintenance
No change this year

References

Cite This Page

Reference Q0517 with the canonical source and edition:

Q0517 — Pharmacy supplying fee for hiv pre-exposure prophylaxis fda approved prescription oral drug, per 60-days. ICD-10 Coding Pro (HCPCS Level II 2026). https://icd10codingpro.com/hcpcs-codes/Q0517

Canonical URL: https://icd10codingpro.com/hcpcs-codes/Q0517

Related Codes in Section Q

Browse all HCPCS Level II sections →
Reviewed by Prajwal Shrestha, CPC, CRC
Certified Professional Coder (CPC) and Certified Risk Adjustment Coder (CRC) · AAPC Member ID 01997614 · About · Editorial policy · Content last reviewed: 2026-01-01

Get HCC Mappings, Clinical Summaries, and More

Access premium features including HCC risk adjustment, FDA drug indications, AI coding assistant, and comprehensive clinical context.

Start Free Trial